Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bacterial vaginosis screening and treatment to prevent preterm complications in high-risk pregnancy
RBR-5wnvtpkNot yet recruiting
- Sponsor
- Faculdade de Medicina da Universidade Federal Fluminense
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of metronidazole in bacterial vaginosis (BV) (2 arms), sponsored by Faculdade de Medicina da Universidade Federal Fluminense. Primary endpoints: Preterm birth and Premature rupture of membranes. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
metronidazole
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on RBR-5wnvtpk.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5wnvtpk.